Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $9.68B | $90.21 | $97.50 | 8.08% | Strong Buy | 4 | 36.72% | 118.55% | 189.22% | 148.15% | |||
| LQDA | LIQUIDIA CORP | $7.02B | $78.93 | $67.00 | -15.11% | Buy | 7 | 70.82% | 203.29% | 560.72% | 151.62% | |||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $41.76B | $312.78 | $436.77 | 39.64% | Strong Buy | 13 | 28.07% | 48.15% | 233.69% | 48.99% | |||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $1.43B | $8.28 | $10.00 | 20.77% | Buy | 1 | 21.00% | 108.66% | 1,840.67% | 61.09% | |||
| KRYS | KRYSTAL BIOTECH INC | $11.06B | $375.07 | $340.56 | -9.20% | Strong Buy | 9 | 28.53% | 20.95% | 67.55% | 61.74% | |||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $4.96B | $64.53 | $64.80 | 0.42% | Strong Buy | 5 | 19.71% | 36.92% | 40.47% | 29.70% | |||
| HALO | HALOZYME THERAPEUTICS INC | $9.42B | $79.45 | $88.60 | 11.52% | Strong Buy | 5 | 13.99% | 56.04% | 525.51% | 43.18% | |||
| VCEL | VERICEL CORP | $2.40B | $46.98 | $53.00 | 12.81% | Strong Buy | 2 | 16.37% | 47.55% | 24.71% | 18.13% | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.40B | $58.99 | $87.94 | 49.07% | Strong Buy | 16 | 15.32% | 73.13% | 26.32% | 19.03% | |||
| RPRX | ROYALTY PHARMA PLC | $33.27B | $57.77 | $61.00 | 5.59% | Strong Buy | 4 | 14.94% | 46.46% | 41.61% | 20.87% | |||
| ADMA | ADMA BIOLOGICS INC | $2.07B | $8.95 | $19.00 | 112.29% | Strong Buy | 2 | 16.15% | 26.72% | 90.04% | 52.84% | |||
| ZVRA | ZEVRA THERAPEUTICS INC | $826.43M | $13.98 | $29.29 | 109.48% | Strong Buy | 7 | 29.42% | 7.50% | 81.82% | 60.44% | |||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $15.28B | $243.47 | $259.25 | 6.48% | Strong Buy | 12 | 6.42% | 297.12% | 44.09% | 16.85% | |||
| ASND | ASCENDIS PHARMA A | $17.05B | $274.50 | $307.20 | 11.91% | Strong Buy | 10 | 34.01% | 9.77% | 263.27% | 64.13% | |||
| TGTX | TG THERAPEUTICS INC | $8.16B | $53.31 | $51.67 | -3.08% | Buy | 3 | 31.45% | 0.06% | 104.97% | 40.04% | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.16B | $37.26 | $39.67 | 6.46% | Hold | 6 | 13.19% | 26.37% | 25.36% | 18.15% | |||
| LGND | LIGAND PHARMACEUTICALS INC | $6.40B | $319.55 | $270.80 | -15.26% | Strong Buy | 5 | 16.44% | 19.87% | 28.31% | 18.43% | |||
| TECH | BIO-TECHNE CORP | $11.09B | $70.83 | $66.22 | -6.51% | Hold | 9 | 8.37% | 54.67% | 19.73% | 16.13% | |||
| SPRO | SPERO THERAPEUTICS INC | $127.38M | $2.20 | N/A | N/A | N/A | N/A | -21.95% | 47.53% | N/A | N/A | |||
| EXEL | EXELIXIS INC | $14.04B | $55.85 | $49.70 | -11.01% | Hold | 10 | 11.54% | 13.74% | 64.63% | 48.24% | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $134.02B | $528.04 | $560.77 | 6.20% | Strong Buy | 17 | 9.70% | 13.70% | 38.20% | 27.93% | |||
| NAGE | NIAGEN BIOSCIENCE INC | $273.18M | $3.43 | $10.50 | 206.12% | Strong Buy | 2 | 15.52% | 16.46% | 41.44% | 29.84% | |||
| UTHR | UNITED THERAPEUTICS CORP | $23.60B | $555.91 | $648.22 | 16.61% | Strong Buy | 9 | 11.60% | 9.04% | 32.70% | 28.74% | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $3.85B | $31.45 | $31.50 | 0.16% | Hold | 2 | 9.32% | 4.46% | 57.07% | 50.36% | |||
| REGN | REGENERON PHARMACEUTICALS INC | $68.59B | $654.27 | $823.61 | 25.88% | Strong Buy | 18 | 9.28% | 14.80% | 24.71% | 19.00% | |||
| VCYT | VERACYTE INC | $4.55B | $57.08 | $49.67 | -12.99% | Buy | 6 | 10.71% | 4.70% | 12.14% | 11.36% | |||
| INCY | INCYTE CORP | $23.35B | $116.86 | $107.33 | -8.15% | Buy | 15 | 7.46% | 11.61% | 14.29% | 10.95% | |||
| SRPT | SAREPTA THERAPEUTICS INC | $2.04B | $19.28 | $26.33 | 36.58% | Hold | 6 | -14.08% | 2.21% | 18.77% | 8.89% | |||
| MDXG | MIMEDX GROUP INC | $588.34M | $3.95 | $7.75 | 96.20% | Strong Buy | 4 | -3.82% | 2.10% | 12.51% | 9.84% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.